| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computer Simulation | 14 | 2019 | 707 | 2.200 |
Why?
|
| Software | 14 | 2019 | 735 | 2.180 |
Why?
|
| Models, Genetic | 9 | 2014 | 789 | 1.250 |
Why?
|
| Mouth Neoplasms | 2 | 2024 | 115 | 1.040 |
Why?
|
| Limonins | 1 | 2024 | 3 | 0.920 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 131 | 0.860 |
Why?
|
| Computational Biology | 5 | 2019 | 890 | 0.820 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2023 | 797 | 0.780 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 272 | 0.760 |
Why?
|
| Apoptosis | 3 | 2024 | 1946 | 0.760 |
Why?
|
| Workflow | 2 | 2019 | 135 | 0.720 |
Why?
|
| Programming Languages | 2 | 2018 | 19 | 0.670 |
Why?
|
| Genetic Variation | 6 | 2014 | 1631 | 0.640 |
Why?
|
| Stem Cell Transplantation | 2 | 2018 | 252 | 0.630 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 872 | 0.590 |
Why?
|
| Stem Cells | 4 | 2024 | 754 | 0.580 |
Why?
|
| Genome, Human | 9 | 2015 | 1351 | 0.570 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 1853 | 0.530 |
Why?
|
| Genome-Wide Association Study | 9 | 2015 | 1880 | 0.490 |
Why?
|
| Disease | 4 | 2014 | 133 | 0.450 |
Why?
|
| Biological Evolution | 4 | 2012 | 256 | 0.440 |
Why?
|
| Alleles | 5 | 2015 | 1724 | 0.400 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2017 | 560 | 0.400 |
Why?
|
| Cell Proliferation | 7 | 2024 | 2563 | 0.370 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 3798 | 0.350 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 2947 | 0.320 |
Why?
|
| Genetics, Population | 2 | 2010 | 198 | 0.300 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2016 | 964 | 0.300 |
Why?
|
| Algorithms | 3 | 2011 | 1736 | 0.290 |
Why?
|
| User-Computer Interface | 3 | 2019 | 167 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1416 | 0.280 |
Why?
|
| Signal Transduction | 7 | 2024 | 4934 | 0.260 |
Why?
|
| Adipose Tissue | 3 | 2024 | 510 | 0.260 |
Why?
|
| Cell Cycle | 2 | 2023 | 628 | 0.260 |
Why?
|
| Internet | 3 | 2018 | 403 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2019 | 253 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 1837 | 0.240 |
Why?
|
| Cellular Senescence | 2 | 2024 | 201 | 0.240 |
Why?
|
| Mice, Inbred NOD | 2 | 2023 | 318 | 0.240 |
Why?
|
| Longevity | 2 | 2024 | 160 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 512 | 0.230 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 48 | 0.230 |
Why?
|
| Mice, SCID | 2 | 2023 | 615 | 0.230 |
Why?
|
| Humans | 36 | 2024 | 134156 | 0.220 |
Why?
|
| Wound Healing | 2 | 2018 | 488 | 0.220 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 56 | 0.210 |
Why?
|
| Kidney Neoplasms | 2 | 2019 | 462 | 0.210 |
Why?
|
| Models, Statistical | 4 | 2014 | 505 | 0.210 |
Why?
|
| Molecular Sequence Annotation | 2 | 2015 | 163 | 0.200 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2023 | 18 | 0.200 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2024 | 352 | 0.200 |
Why?
|
| Mice | 9 | 2024 | 19055 | 0.190 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 868 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 616 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 535 | 0.180 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3043 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2024 | 915 | 0.180 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2021 | 17 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2017 | 3506 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2018 | 877 | 0.170 |
Why?
|
| Antioxidants | 1 | 2023 | 378 | 0.170 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2020 | 9 | 0.170 |
Why?
|
| Histone Deacetylase 6 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 129 | 0.160 |
Why?
|
| Hyperalgesia | 1 | 2019 | 28 | 0.160 |
Why?
|
| Animals | 11 | 2024 | 36557 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 825 | 0.160 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2019 | 12 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 426 | 0.160 |
Why?
|
| Epidermis | 1 | 2019 | 66 | 0.160 |
Why?
|
| Nicotine | 1 | 2021 | 147 | 0.160 |
Why?
|
| Neuralgia | 1 | 2020 | 55 | 0.160 |
Why?
|
| Computing Methodologies | 1 | 2019 | 1 | 0.160 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 13 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2019 | 106 | 0.150 |
Why?
|
| Stomatitis, Aphthous | 1 | 2018 | 3 | 0.150 |
Why?
|
| Nitrosative Stress | 1 | 2018 | 3 | 0.150 |
Why?
|
| Naphthoquinones | 1 | 2018 | 9 | 0.150 |
Why?
|
| Eye Neoplasms | 1 | 2018 | 53 | 0.150 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2018 | 19 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 138 | 0.150 |
Why?
|
| Evolution, Molecular | 2 | 2013 | 710 | 0.150 |
Why?
|
| Cisplatin | 1 | 2019 | 287 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 72 | 0.140 |
Why?
|
| Microcirculation | 1 | 2018 | 117 | 0.140 |
Why?
|
| Bandages | 1 | 2018 | 59 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 370 | 0.140 |
Why?
|
| Ureteral Neoplasms | 1 | 2017 | 27 | 0.140 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2017 | 52 | 0.140 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2017 | 37 | 0.140 |
Why?
|
| Dermatomyositis | 2 | 2015 | 35 | 0.140 |
Why?
|
| Hydrogels | 1 | 2018 | 109 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2017 | 46 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 83 | 0.130 |
Why?
|
| Research | 1 | 2019 | 272 | 0.130 |
Why?
|
| Urothelium | 1 | 2017 | 60 | 0.130 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2016 | 5 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 161 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 324 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2018 | 370 | 0.130 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 204 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2016 | 74 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 652 | 0.130 |
Why?
|
| Multigene Family | 1 | 2017 | 324 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2018 | 242 | 0.120 |
Why?
|
| Ureter | 1 | 2017 | 100 | 0.120 |
Why?
|
| Genotype | 4 | 2014 | 2814 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 393 | 0.120 |
Why?
|
| Gene Frequency | 3 | 2014 | 779 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 262 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 165 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2020 | 928 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 288 | 0.120 |
Why?
|
| Skin | 1 | 2018 | 545 | 0.110 |
Why?
|
| Cell Movement | 3 | 2024 | 920 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2016 | 451 | 0.110 |
Why?
|
| Myositis | 1 | 2015 | 104 | 0.110 |
Why?
|
| Mutation | 4 | 2018 | 6338 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2015 | 254 | 0.110 |
Why?
|
| Genomics | 3 | 2017 | 1681 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 40 | 0.110 |
Why?
|
| Quality Control | 1 | 2014 | 126 | 0.110 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 112 | 0.110 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 396 | 0.110 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 7 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 352 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 628 | 0.110 |
Why?
|
| Carcinogenesis | 1 | 2016 | 364 | 0.100 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1721 | 0.100 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 131 | 0.100 |
Why?
|
| Insulin | 1 | 2018 | 1260 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2018 | 700 | 0.100 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 333 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2014 | 345 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 353 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 720 | 0.090 |
Why?
|
| Fertility | 1 | 2013 | 270 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 456 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 279 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 407 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1167 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 196 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 1034 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 617 | 0.080 |
Why?
|
| Ganglia, Spinal | 2 | 2020 | 73 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 2137 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 239 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2018 | 3668 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2010 | 635 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2915 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2013 | 1719 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 951 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2006 | 82 | 0.060 |
Why?
|
| Male | 11 | 2024 | 66127 | 0.060 |
Why?
|
| Aging | 2 | 2024 | 1306 | 0.060 |
Why?
|
| Base Sequence | 1 | 2011 | 3180 | 0.060 |
Why?
|
| Neoplasms | 2 | 2018 | 3038 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2006 | 169 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 247 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2009 | 811 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 296 | 0.060 |
Why?
|
| Aged | 7 | 2019 | 21775 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2005 | 40 | 0.060 |
Why?
|
| Diploidy | 1 | 2005 | 39 | 0.060 |
Why?
|
| Genetics | 1 | 2005 | 25 | 0.060 |
Why?
|
| Time | 1 | 2005 | 101 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4808 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 70 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2024 | 151 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2004 | 141 | 0.050 |
Why?
|
| Female | 11 | 2019 | 71928 | 0.050 |
Why?
|
| Middle Aged | 7 | 2019 | 29399 | 0.050 |
Why?
|
| Chondroitin Sulfates | 1 | 2023 | 15 | 0.050 |
Why?
|
| Fishes | 1 | 2023 | 42 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 401 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2004 | 303 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2017 | 440 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 426 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2023 | 152 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2004 | 406 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2446 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 4016 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 249 | 0.040 |
Why?
|
| Meninges | 1 | 2020 | 22 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 1787 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2020 | 63 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1923 | 0.040 |
Why?
|
| Proteomics | 1 | 2004 | 599 | 0.040 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2020 | 40 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1539 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2019 | 76 | 0.040 |
Why?
|
| Isotopes | 1 | 2019 | 27 | 0.040 |
Why?
|
| Neoplasms, Adnexal and Skin Appendage | 1 | 2018 | 5 | 0.040 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 18 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2019 | 261 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 223 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2011 | 827 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 285 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2018 | 37 | 0.040 |
Why?
|
| Gene Expression | 1 | 2023 | 1621 | 0.040 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2018 | 24 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2018 | 141 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 245 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2020 | 149 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2018 | 191 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2017 | 49 | 0.030 |
Why?
|
| Allografts | 1 | 2018 | 198 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2017 | 72 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 31945 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2018 | 214 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1356 | 0.030 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 2045 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7217 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 544 | 0.030 |
Why?
|
| K562 Cells | 1 | 2016 | 100 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 440 | 0.030 |
Why?
|
| Cloud Computing | 1 | 2015 | 14 | 0.030 |
Why?
|
| Phenotype | 2 | 2017 | 4598 | 0.030 |
Why?
|
| Polymyositis | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 890 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 134 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 843 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 313 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 920 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6610 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 507 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 500 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 231 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1219 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1472 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1488 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 162 | 0.030 |
Why?
|
| Sample Size | 1 | 2014 | 88 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 723 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 220 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 709 | 0.030 |
Why?
|
| Haplotypes | 1 | 2015 | 560 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 102 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 20624 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1258 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 3743 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2014 | 168 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 334 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2172 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1071 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1138 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 468 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 11182 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1979 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 2771 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 2050 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 146 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3716 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3434 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 268 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5086 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4879 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2017 | 13074 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 69 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2005 | 122 | 0.010 |
Why?
|
| Research Design | 1 | 2009 | 748 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 153 | 0.010 |
Why?
|
| Mastectomy | 1 | 2004 | 82 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 967 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 9944 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 237 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2004 | 143 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 756 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 311 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 376 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17540 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1599 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 1391 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2198 | 0.010 |
Why?
|